LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Low‐dose systemic thrombolytic therapy for treatment of submassive pulmonary embolism: Clinical efficacy but attendant hemorrhagic risks

Photo by towfiqu999999 from unsplash

The purpose of the present study is to evaluate the safety and efficacy of “low‐dose” systemic thrombolytic therapy (TT) for treatment of patients with intermediate‐high risk submassive pulmonary embolism (PE). Click to show full abstract

The purpose of the present study is to evaluate the safety and efficacy of “low‐dose” systemic thrombolytic therapy (TT) for treatment of patients with intermediate‐high risk submassive pulmonary embolism (PE).

Keywords: dose systemic; low dose; systemic thrombolytic; thrombolytic therapy; submassive pulmonary; therapy treatment

Journal Title: Catheterization and Cardiovascular Interventions
Year Published: 2019

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.